SCDT-19. DELIVERY OF ISPINESIB IS LIMITED BY EFFLUX TRANSPORT AT THE BLOOD-BRAIN BARRIER (BBB)

PURPOSE: A challenge in developing therapies for GBM is the inability of drugs to cross the BBB. Ispinesib, an inhibitor of kinesin spindle protein, has potent anti-cancer activity by causing mitotic arrest and growth inhibition. The objective was to determine the distribution of ispinesib across th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Gampa, Gautham, Crish, James, Parrish, Karen, Cook-Rostie, Nicholas, Kim, Minjee, Laramy, Janice, Rosenfeld, Steven, Elmquist, William
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692963/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.1102
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados